T
Power Law company profile
Tevogen Bio
Biotech & Life Sciences · Metuchen, United States · Founded 2020 Unicorn
Valuation
$1.20B
Market cap · 2026
Global footprint
Where Tevogen Bio has talent and traffic
Web traffic by country
9.4K
monthly visits
across markets
across markets
🇺🇸 United States100%
Patent intelligence
$168k patent portfolio · 3 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$168k
0.01% of market cap · 202.3× smaller than top peer Centessa Pharmaceuticals ($34M)
3 active patent families
Where Tevogen Bio innovates
PeptideCytotoxic T cellMolecular biologyCD3Pharmaceutical drug
Below peer median on Strategic, Market
Quality vs same-sector peers
Tevogen Bio on the five Patsnap quality dimensions
Tevogen Bio in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Tevogen Bio concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Tevogen Bio and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Tevogen Bio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.